Kestra Medical Technologies, Ltd. Amortization of Debt Issuance Costs and Discounts
Kestra Medical Technologies, Ltd. (KMTS) reported Amortization of Debt Issuance Costs and Discounts of $408.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. amortization of debt issuance costs and discounts for the quarter ending 2026-07-31 was $408.00K, a 13.01% decline year-over-year.
- Kestra Medical Technologies, Ltd. amortization of debt issuance costs and discounts for the quarter ending 2026-04-30 was $468.00K, a 26.83% increase year-over-year.
- Kestra Medical Technologies, Ltd. amortization of debt issuance costs and discounts for the quarter ending 2026-01-31 was $469.00K, a 175.88% increase year-over-year.
- Kestra Medical Technologies, Ltd. amortization of debt issuance costs and discounts for the quarter ending 2025-10-31 was $468.00K, a 29.20% decline year-over-year.
- Kestra Medical Technologies, Ltd. amortization of debt issuance costs and discounts for fiscal 2026 was $1.87M, a 33.86% increase from fiscal 2025.
- Kestra Medical Technologies, Ltd. amortization of debt issuance costs and discounts for fiscal 2025 was $1.40M, a 129.51% increase from fiscal 2024.
- Kestra Medical Technologies, Ltd. amortization of debt issuance costs and discounts for fiscal 2024 was $610.00K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2026-07-31 | $408.00K 10-Q · filed 2026-09-14 | $876.00K derived: sum of 2 quarters · filed 2026-09-14 | $1.34M derived: sum of 3 quarters · filed 2026-09-14 | $1.81M derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | $468.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $937.00K derived: sum of 2 quarters · filed 2026-07-14 | $1.41M derived: sum of 3 quarters · filed 2026-07-14 | $1.87M 10-K · filed 2026-07-14 |
| 2026-01-31 | $469.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | $937.00K derived: sum of 2 quarters · filed 2026-03-17 | $1.41M 10-Q · filed 2026-03-17 | $1.77M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | $468.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | $937.00K 10-Q · filed 2025-12-11 | $1.31M derived: sum of 3 quarters · filed 2026-09-14 | $1.48M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | $469.00K 10-Q · filed 2026-09-14 | $838.00K derived: sum of 2 quarters · filed 2026-09-14 | $1.01M derived: sum of 3 quarters · filed 2026-09-14 | $1.67M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | $369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $539.00K derived: sum of 2 quarters · filed 2026-07-14 | $1.20M derived: sum of 3 quarters · filed 2026-07-14 | $1.40M 10-K · filed 2026-07-14 |
| 2025-01-31 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | $831.00K derived: sum of 2 quarters · filed 2026-03-17 | $1.03M 10-Q · filed 2026-03-17 | |
| 2024-10-31 | $661.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | $861.00K 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | $200.00K 10-Q · filed 2025-09-12 | |||
| 2024-04-30 | $610.00K 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |